advertisement

---

Traverso CE 15

Showing records 1 to 15 | Display all abstracts from Traverso CE

90566 Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma
Cirafici P; Cirafici P
Eye 2021; 35: 868-876

---

89967 An update on ripasudil for the treatment of glaucoma and ocular hypertension
Testa V
Drugs of Today 2020; 56: 599-608

---

90392 Neuroinflammation in Primary Open-Angle Glaucoma
Vernazza S
Journal of clinical medicine 2020; 9:

---

90566 Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma
Maiello G
Eye 2021; 35: 868-876

---

89967 An update on ripasudil for the treatment of glaucoma and ocular hypertension
Ferro Desideri L
Drugs of Today 2020; 56: 599-608

---

90392 Neuroinflammation in Primary Open-Angle Glaucoma
Tirendi S
Journal of clinical medicine 2020; 9:

---

89967 An update on ripasudil for the treatment of glaucoma and ocular hypertension
Della Giustina P
Drugs of Today 2020; 56: 599-608

---

90392 Neuroinflammation in Primary Open-Angle Glaucoma
Bassi AM
Journal of clinical medicine 2020; 9:

---

90566 Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma
Ancona C
Eye 2021; 35: 868-876

---

90392 Neuroinflammation in Primary Open-Angle Glaucoma
Traverso CE
Journal of clinical medicine 2020; 9:

---

89967 An update on ripasudil for the treatment of glaucoma and ocular hypertension
Traverso CE
Drugs of Today 2020; 56: 599-608

---

90566 Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma
Masala A; Traverso CE
Eye 2021; 35: 868-876

---

90392 Neuroinflammation in Primary Open-Angle Glaucoma
Saccà SC
Journal of clinical medicine 2020; 9:

---

89967 An update on ripasudil for the treatment of glaucoma and ocular hypertension
Iester M
Drugs of Today 2020; 56: 599-608

---

90566 Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma
Iester M
Eye 2021; 35: 868-876

---